Abstract
Diffuse loss of scalp hair, even when no scars are left behind, has always been felt to constitute the loss of a major cosmetic attribute. In some cultures and for millions of people, hair represents the crown of beauty.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Achten G, Wannet-Rouard J (1971) Trichogramme et medecine légale. Arch Belg Derm Syph 27:353–359
Adachi K (1973) The metabolism and control mechanism of human hair follicles. Curr Probi Dermatol 5:37–78
Allegra F (1968) Histology and histochemical aspects of the hair follicles in pattern alopecia. In: Baccaredda-Boy A, Moretti G, Frey JR (eds) Biopathology of pattern alopecia. Karger, Basel, pp 107–128
Aram H (1987) Treatment of female androgenetic alopecia with Cimetidine. Intern J Derm 26:128–130
Baden HP, Kubilus J (1983) Effect of minoxidil on cultured keratinocytes. J Invest Dermatol 81:558–560
Baral J (1985) Scalp comedones after topical minoxidil. J Am Acad Dermatol 13:1051
Barman JM, Astore J, Pecoraro V (1965) The normal trichogram of the adult. J Invest Dermatol 44:233–236
Barman JM, Astore J, Pecoraro V (1967) The normal trichogram of people over 50 years but apparently not bald. In: Montagna W, Dobson R (eds) Advances in biology of skin hair growth. Pergamon, Oxford, pp 211–220
Barnes EW, Irvine WJ, Hunter WM, Ismail AAA (1975) Cyproterone acetate: a study involving two volunteers with idiopathic hirsutism. Clin Endocrinol 4:65–73
Bassas E, Pinto E (1974) Experimental study on male pattern alopecia. Arch Dermatol Forsch 248:339–346
Bazzano GS, Terezakis N, Galen W (1986) Topical tretinoin for hair growth promotion. J Am Acad Dermatol 15:880–893
Beek CH (1950) A study on extension and distribution of the human body-hair. Dermatologica 101:317–333
Behrman HT (1952) The scalp in health and disease. Mosby, St. Louis, pp 173–183
Belaube B, Devaux J, Gamby T, Garcin G, Privat Y (1982) Place de l’hormonotherapie dans le traitement de l’acné, de l’hirsutisme idiopathique et des alopécies seborrheiques. Sem Hop Paris 58:1650–1653
Bingham KD, Shaw DA (1973) The metabolism of testosterone by human scalp skin. J Endocrinol 57:111–121
Bouton MM, Lecaque D, Secchi J, Tournemine C (1986) Effect of a new, topically active antiandrogen (RU 38882) on the rat sebaceous gland: comparison with cyproterone acetate. J Invest Dermatol 86:163–167
Braendle W, Boess H, Breckwoldt M, Leven Ch, Bettendorf G (1974) Wirkung und Nebenwirkung von Cyproteronazetat-Behandlung. Arch Gynäkol 216:335–345
Braun-Falco O, Heilgemeir GP (1977) Aussage der Haarwurzelstatusmethode. Hautarzt 28:136–139
Burke GM, Cunliffe WJ (1985) Oral spironolactone therapy for female patients with acne, hirsutism or androgenic alopecia. Br J Dermatol 112:124–125
Burton JL, Marshall A (1979) Hypertrichosis due to minoxidil. Br J Dermatol 101:593–595
Burton JL, Schutt WH, Caldwell IW (1975) Hypertrichosis due to diazoxide. Br J Dermatol 93:707–711
Burton JL, Ben Halim MM, Meyrick G, Jeans WD, Murphy D (1979) Male-pattern alopecia and masculinity. Br J Dermatol 100:567–571
Cipriani R, Ruzza G, Foresta G (1983) Sex hormone binding globulin and saliva testosterone levels in men with androgenetic alopecia. Br J Dermatol 109:249–252
Cohen RL, Alves MEAF, Weiss VC et al. (1984) Direct effects of minoxidil on epidermal cells in culture. J Invest Dermatol 82:90–93
Crovato F, Moretti G, Bertamino R (1968) Histochemistry of dermis and blood vessels in male pattern alopecia. In: Baccaredda-Boy A, Moretti G, Frey JR (eds) Biopathology of pattern alopecia. Karger, Basel, pp 191–199
Crovato F, Moretti G, Bertamino R (1973) 17-beta-hydroxysteroid-dehydrogenases in hair follicles of normal and bald scalp: a histochemical study. J Invest Dermatol 60:126–133
Cumming DC, Yang JC, Rebar RW, Yen SSC (1982) Treatment of hirsutism with spironolactone. JAMA 247:1295–1298
Dargie HJ, Dollery CT, Daniel J (1977) Minoxidil in resistant hypertension. Lancet 11:515–518
Dawber RPR, Sonnex T, Ralfs I (1982) Oral antiandrogen treatment in women. Br J Dermatol 107, Suppl 22:20
De Boer EM, Bezemer PD, Bruynzeel DP, Nieboer C (1988) Does topical minoxidil increase skin blood flow? A laser Doppler flowmetry study. Acta Derm Venereol 68:271–274
De Graf H, Hendrickx I, Dooms-Goossens A (1985) Allergic contact dermatitis to minoxidil. Contact Dermatitis 13:194–195
De Villez RL (1985) Topical minoxidil therapy in hereditary androgenetic alopecia. Arch Dermatol 121:197–202
De Villez RL, Dunn J (1986) Female androgenic alopecia. Arch Dermatol 122:1011–1015
Dijkstra AC, Goos MAA, Cunliffe WJ (1987) Is increased 5a-reductase activity a primary phenomenon in androgen-dependent skin disorders? J Invest Dermatol 89:87–92
Ebling F J (1973) The effects of cyproterone acetate and oestradiol upon testosterone stimulated sebaceous activity in the rat. Acta Endocrinol (Copenhagen) 72:361–365
Ebling F J, Thomas AK, Cooke ID, Randall VA, Skinner J, Cawood M (1977) Effect of cyproterone acetate on hair growth, sebaceous secretion and endocrine parameters in a hirsute subject. Br J Dermatol 97:371–381
Eckert J (1975) Diffuse hair loss and psychiatric disturbances. Acta Dermatol 55:147–149
Eckert J, Church RE, Ebling F J, Munro DS (1967) Hair loss in women. Br J Dermatol 79:543–548
Editorial (1986) Unapproved use of minoxidil. J Am Acad Dermatol 14:828–829
Eil CH, Edelson SK (1984) The use of human skin fibroblasts to obtain potency estimates of drug binding to androgen receptors. J Clin Endocrinol Metabol 59:51–55
Ekoe TM, Burchardt P, Reredi B (1980) Treatment of hirsutism, acne and alopecia with cyproterone acetate. Dermatológica 160:338–345
Emons G, Diedrich K, Krebs D, Knuppen R (1984) Postmenopausenblutung nach Anwendung eines östrogenhaltigen Haarwassers — begleitende endokrine Veränderungen. Geburtsh Frauenheilkd 44:460–462
Feinstein R (1985) The effect of topical minoxidil on blood pressure. J Am Acad Dermatol 13:673–674
Fenton DA, English JS, Wilkinson JD (1982) Reversal of male pattern baldness, hypertrichosis and accelerated hair and nail growth in patients receiving benoxaprofen. Br Med J 284:1228–1230
Ferrari RA, Chakrabarty K, Beyler AL, Wiland J (1978) Suppression of sebaceous glands in laboratory animals by 17a-propyltestosterone. J Invest Dermatol 71:320–323
Fiedler-Weiss VC, West DP, Buys CM, Rumsfield JA (1986) Topical minoxidil dose-response effect in alopecia areata. Arch Dermatol 122:180–182
Fiedler VC, Buys CM (1987) Immunohistochemical characterization of the cellular infiltrate in severe alopecia areata before and after minoxidil treatment. Dermatológica 175, Suppl 2:29–35
Franz TJ (1985) Percutaneous absorption of minoxidil in man. Arch Dermatol 121:203–206
Futterweit W (1984) Pathophysiology of polycystic ovarian disease. In: Futterweit W (ed) Polycystic ovarian disease. Springer, Berlin Heidelberg New York, pp 49–82
Futterweit W, Dunait A, Hsu-Chong Yeh, Kingsley P (1988) The prevalence of hyperandrogenism in 109 consecutive female patients with diffuse alopecia. J Am Acad Derm 19:831–836
Georgala G, Papasotiriou V, Stavropoulos P (1986) Serum testosterone and sex hormone binding globulin levels in women with androgenetic alopecia. Acta Derm Venereol 66:532–534
Giacometti L, Montagna W (1968) The nerve fibers in male pattern alopecia. In: Baccaredda-Boy A, Moretti G, Frey JR (eds) Biopathology of pattern alopecia. Karger, Basel, pp 208–215
Gibbons RD, Fiedler-Weiss VC, West DP, Lapin G (1986) Quantification of scalp hair — a computer-aided methodology. J Invest Dermatol 86:78–82
Gilliland JM, Kirk J, Smeaton TC (1981) Normalized androgen ratio: its application in clinical dermatology. Clin Exper Dermatol 6:349–353
Green MR, Couchman JR (1984) Distribution of epidermal growth factor receptors in rat tissues during embryonic skin development, hair formation, and the adult hair growth cycle. J Invest Dermatol 83:118–123
Grosshans E, Chepfer MP, Maleville J (1972) Le trichogramme. A propos d’une méthode d’étude des cheveux. J Med Strasbourg 2:378–384
Groveman HD, Ganiats T, Klauber MR (1985) Lack of efficacy of polysorbate 60 in the treatment of male pattern baldness. Arch Intern Med 145:1454–1458
Guy WB, Edmundsen WF (1960) Diffuse cyclic hair loss in women. Arch Dermatol 81:205–207
Hamilton JB (1942) Male hormone stimulation is prerequisite and an incitant in common baldness. Am J Anat 71:451–480
Hamilton JB (1951) Patterned loss of hair in man; types and incidence. Ann NY Acad Sci 53:708–728
Hammerstein J, Meckies J, Leo-Rossberg I, Moltz L, Zielske F (1975) Use of cyproterone acetate (CPA) in the treatment of acne, hirsutism and virilism. J Steroid Biochem 6:827–836
Harris H (1946) The inheritance of premature baldness in man. Ann Eugenics 13:172
Hay JB (1977) A study of the in vitro metabolism of androgens by human scalp and pubic skin. Br J Dermatol 97:237–246
Headington JT (1987) Hair follicle biology and topical minoxidil: possible mechanisms of action. Dermatologica 175, Suppl 2:19–22
Headington JT, Novak E (1984) Clinical and histologic studies of male pattern baldness with topical minoxidil. Curr Ther Res 36:1098–1106
Hertel H, Gollnick H, Matthies C, Baumann I, Orfanos CE (1988) Low dose retinol and L-cystin improve alopecia of diffuse type after long-term oral application. In: Orfanos CE, Stadler R, Gollnick H (eds) Dermatology in five continents. Springer, Berlin Heidelberg New York, pp 1164–1167
Hoffmann E, Meirs HG, Hubbes A (1974) Wirkungen von Antikonzeptiva auf Alopecia androgenetica, Seborrhoea oleosa, Akne vulgaris und Hirsutismus. Dtsch Med Wschr 99:2151–2157
Hori H, Moretti G, Rebora A, Crovato F (1972) The thickness of human scalp: normal and bald. J Invest Dermatol 58:396–399
Jackson D, Church RE, Ebling FJ (1972) Hair diameter in female baldness. Br J Dermatol 87:361–367
James KC, Rushton DH (1983) Evaluation techniques for male pattern baldness. J Am Acad Dermatol 14:849–850
Jenkins JS, Ash S (1973) The metabolism of testosterone by human skin in disorders of hair growth. J Endocrinol 59:345–351
Jost B, Meiers HG, Schmidt-Eimendorff H, Pfaffenrath V (1974) Trichometrische Quantifizierung und Verlaufsbeurteilung des Hirsutismus. Dtsch Med Wschr 99:2395–2400
Kaiser E (1984) Wirkung eines neuen hormonalen Antikonzeptivums (Neo-Eunomin) bei Frauen mit Androgenisierungserscheinungen. Geburtsh Frauenheilkd 44:651–655
Kaszynski E (1983) The stimulation of hair growth in the flank organs of female hamsters by subcutaneous testosterone propionate and its inhibition by topial cyproterone acetate: doseresponse studies. Br J Dermatol 109:565–569
Kolb KH, Schulze PE (1971) Über die kutane Penetration von Sexualsteroidhormonen. Symp Dtsch Ges Endocrinol 17, Springer, Berlin Heidelberg New York, pp 49–56
Kuester W, Happle R (1984) The inheritance of common baldness: two B or not two B? J Am Acad Dermatol 11:921–926
Kuhlwein A (1985) Androgene Alopecie vom weiblichen Typ beim Mann. Z Hautkr 60:576–578
Lattanand A, Johnson WC (1975) Male pattern alopecia. A histopathologic study. J Cutan Pathol 2:58–70
Lester Gabrilove J, Luria M (1978) Persistent gynecomastia resulting from scalp injunction of estradiol. Arch Dermatol 114:1672–1673
Lobo RA, Shoupe D, Serafini P, Brinton D, Horton R (1985) The effects of two doses of spironolactone on serum androgens and anagen hair in hirsute women. Fert Steril 43:200–205
Lookingbill DP, Horton R, Demers LM, Egan N, Marks JG, Santen RJ (1985) Tissue production of androgens in women with acne. J Am Acad Dermatol 12:481–487
Lucky AW, McGuire J, Nydorf E, Halpert G, Nuck BA (1986) Hair follicle response of the golden Syrian hamster flank organ to continuous testosterone stimulation using silastic capsules. J Invest Dermatol 86:83–86
Luderschmidt C, Eiermann W, Jawny J, Bidlingmaier F, Ring J (1984) 17a-propylmesterolone (Sch 434): an antiandrogenic sebosuppressive substance not influencing circulating testosterone concentrations. Naunyn-Schmiedeberg’s Arch Pharmacol 328:214–216
Ludwig E (1964) Die androgenetische Alopezie bei der Frau. Arch Klin Exp Dermatol 219:558–564
Ludwig E (1977) Classification of the types of androgenetic alopecia (common baldness) occurring in the female sex. Br J Dermatol 97:247–254
Lutsky BN, Budak M, Koziol P, Monahan M, Neri RO (1975) The effects of a nonsteroid antiandrogen, flutamide, on sebaceous gland activity. J Invest Dermatol 64:412–117
Maguire HC, Kligman AM (1962) The histopathology of common male baldness. In: Proceedings of the Xllth International Congress of Dermatology, Washington. Excerpta Medica, Amsterdam, p 1438
Maguire HC, Kligman AM (1964) Hair plucking as a diagnostic tool. J Invest Dermatol 43:77–79
Maibach HI, Feldmann R, Payne B, Hutshell T (1968) Scalp and forehead sebum production on male patterned alopecia. In: Baccaredda-Boy A, Moretti G, Frey JR (eds) Biopathology of pattern alopecia. Karger, Basel, pp 171–176
Matias JR, Orentreich N, Malloy V, De Feo CP, Matias L (1984) The lack of effect of lla-hydroxyprogesterone on the flank organ and ear sebaceous glands in adult male Syrian golden hamsters. Arch Dermatol Res 276:346–348
Maurer C, von Seebach HB, Loskant G (1983) Uterine Blutung im Senium nach Langzeitanwendung östrogenhaltigen Haarwassers. Dt Med Wschr 108:1097–1099
Meiers HG (1975) Trichogramm (= Haarwurzelstatus, = Haarbild). Methode und Aussagefähigkeit. Akt Dermatol 1:31–32
Meiers HG, Grobbel B (1974) Das Kopfhaar im Alter. Z Geront 7:427–30
Meiers HG, Rechenberger HG, Rechenberger J (1973) Trichotillomanie. Untersuchungen zur Ätiologie, Diagnostik und Therapie. Hautarzt 24:248–252
Meisheri KD, Cipkem LA (1987) Biochemical mechanisms by which minoxidil sulfate influences mammalian cells. Dermatologica 175, Suppl 2:3–11
Metz HG, Landes E (1970) Der Haarausfall und seine Untersuchung. Fortschr Med 88:1327–1328
Miller JA, Darley CR, Karkavitsas K, Kirby JD, Munro DD (1982) Low sex-hormone binding globulin levels in young women with diffuse hair loss. Br J Dermatol 106:331–336
Miyazaki M, Takayasu S, Karakawa T, Aono T, Kurachi K, Matsumoto K (1978) Activity of testosterone 5a-reductase in the hair follicles of women with polycystic ovaries. J Endocr 78:445–446
Moltz L, Haase F, Schwartz U, Hammerstein J (1983) Die Behandlung androgenisierter Frauen mit intramuskulär applizierbarem Cyproteronacetat. Geburtsh Frauenheilkd 43:281–287
Moltz L, Schwartz U, Sörensen R, Pickartz H, Hammerstein J (1984) Ovarian and adrenal vein steroids in patients with nonneoplastic hyperandrogenism: selective catheterization findings. Fert Steril 42:69–75
Morales-Alanis H, Brienne MJ, Jacques J, Bouton MM, Nedelec L, Torelli V, Tournemine C (1985) Antiandrogenic activity of a series of Des-A-steroid derivatives. J Med Chem 28:1796–1803
Mortimer CH, Rushton H, James KC (1984) Effective medical treatment for common baldness in women. Clin Exp Dermatol 9:342–350
Muller SA (1973) Alopecia. Syndromes of genetic significance. J Invest Dermatol 60:475–492
Neale C, Krebs D, Bettendorf G (1971) Behandlung der Akne, des Hirsutismus und der Alopezie mit Cyproteronazetat und Äthinylöstradiol. Acta Endocrin (Kopenhagen) 66, Suppl 152:13
Neumann F, Elger DVM (1966) The effect of a new antiandrogenic steroid, 6-chloro-17-hydroxy-la,2-methylenepregna-4,6-diene-3,20-dione acetate (cyproterone acetate) on the sebaceous glands of mice. J Invest Dermatol 46:561–573
Nielsen PG (1982 a) Treatment of idiopathic hirsutism with spironolactone. Dermatologica 165:194–196
Nielsen PG (1982 b) Treatment of moderate idiopathic hirsutism with a cream containing can-renone (an antiandrogen). Dermatologica 165:636–639
Nietzschmann F (1982) Lokale Östrogenapplikation bei androgenetischer Alopezie. Dissertation, Freie Universität, Berlin
Nuck BA, Lucky AW (1987) Epitestosterone: a potential new antiandrogen. J Invest Dermatol 89:209–211
Nuck BA, Fogelson S, Lucky AW (1987) Topical minoxidil does not act as an antiandrogen in the flank organ of the golden Syrian hamster. Arch Dermatol 123:59–61
Olsen EA, Weiner SM, Delong ER, Pinell SR (1985) Topical minoxidil in early male pattern baldness. J Am Acad Dermatol 13:185–192
Olsen EA, Delong ER, Weiner MS (1986) Dose-response study of topical minoxidil in male pattern baldness. J Am Acad Dermatol 15:30–37
Orentreich N (1959) Autographs in alopecias and other selected dermatological conditions. Ann NY Acad Sci 83:463–79
Orentreich N (1960) Pathogenesis of alopecia. J Soc Cosm Chem 11:479–199
Orfanos CE, Brückner L (1982) Messungen der Haardichte anormaler menschlicher Kopfhaut mit und ohne kosmetische Vorbehandlung. Akt Dermatol 8:222–224
Orfanos CE, Hertel H (1988) Haarwachstumsstörungen bei Hyperprolaktinämie. Z Hautkr 63:23–26
Orfanos CE, Vogels L (1980) Lokaltherpaie der alopecia androgenetic mit 17alpha-Oestradiol. Eine kontrollierte, randomisierte Doppelblindstudie. Dermatologica 161:124–132
Orfanos CE, Wüstner H (1975) Penetration und Nebenwirkungen lokaler Östrogenapplikation bei Alopecia androgenetica. Hautarzt 26:367–369
Orfanos CE, Meiers HG, Friederich HC, Ludwig E, Mahrle G, Zaun H (1974) Haarausfall, Trichogramm und hormonelle Haartherapeutica. Dtsch Ärztbl 3603–3608
Panteleos D, Orfanos CE (1976) Die Aufnahme und therapeutische Anwendung von lokal appliziertem Östrogen. Ärztl Kosmetol 6:159–163
Papa CM, Kligman AM (1965) Stimulation of hair growth by topical application of androgens. J Am Med Assoc 191:521–525
Passchier J, van der Donk J, Dutree-Meulenberg ROGM, Stolz E, Verhage F (1988) Psychological characteristics of men with androgenetic alopecia and effects of treatment with topical minoxidil. Int J Dermatol 27, Suppl 6:441–46
Pecoraro V, Astore J, Barman J, Araujo CS (1964) The normal trichogram in the child before the age of puberty. J Invest Dermatol 42:427–130
Peereboom-Wynia JDR, Beek CH (1977) The influence of cyproterone acetate orally on the hair root status in women with idiopathic hirsutism. Arch Dermatol Res 260:137–142
Peereboom-Wynia JDR, Boekhorst JC (1980) Effect of cyproterone acetate orally on hair density and diameter, and endocrine factors in women with idiopathic hirsutism. Dermatologica 160:7–16
Pinneil SR, Murad S (1987) Effects of minoxidil on cultured human skin fibroblasts. Dermatologica 175, Suppl 2:12–18
Pria SD, Greenblatt RB, Mahesh VB (1969) An antiandrogen in acne and idiopathic hirsutism. J Invest Dermatol 52:348–350
Price VH (1975) Testosterone metabolism in the skin. Arch Dermatol 111:1496–1502
Rampini E, Bertamino R, Moretti G (1968) Size and shape of sebaceous glands in male pattern alopecia. In: Baccaredda-Boy A, Moretti G, Frey JR (eds) Biopathology of pattern alopecia. Karger, Basel, pp 155–165
Ranchoff RE, Bergfeld WF (1985) Topical minoxidil reduces blood pressure. J Am Acad Dermatol 12:586–587
Raynaud JP, Bonne C, Bouton MM (1979) Action of a nonsteroidal antiandrogen, RU 23908, in peripheral and central tissue. J Steroid Biochem 11:93–95
Rentoul JR (1983) Management of the hirsute woman. Int J Dermatol 22:265–272
Rittmaster RS, Loriaux L (1987) Hirsutism. Ann Int Med 106:95–107
Rittmaster RS, Uno H, Povar ML, Mellin TN, Loriaux DL (1987) The effects of N,N-diethyl4-methyl-3-oxo-4-aza-5a-androstane-17j5-carboxamide, a 5a-reductase inhibitor and antiandrogen, on the development of baldness in the stumptail macaque. J Clin Endocrinol 65:188–193
Roenigk HH, Pepper E (1985) Topical minoxidil therapy for hereditary male pattern alopecia. Clin Res 33:914A
Rook A (1977) Common baldness and alopecia areata. In: Rook A (ed) Recent advances in dermatology, vol 4. Churchill Livingstone, Edinburgh, pp 223–247
Runne U, Martin H (1986) Veränderungen von Telogenrate, Haardichte, Haardurchmesser und Wachstumsgeschwindigkeit bei der androgene tischen Alopezie des Mannes. Hautarzt 37:198–204
Rushton H, James KC, Mortimer CH (1983) The unit area trichogram in the asessment of an-drogen-dependent alopecia. Br J Dermatol 109:429–437
Rushton DH, Vuger WP, Cotterill PC, Kingsley P, James KC (1989) Quantitative assessment of 2% topical minoxidil in the treatment of male pattern baldness. Clin Exp Dermatol 14:40–46
Salamon T (1966) Vererbung von Haar- und Nagelkrankheiten. In: Jadassohn J (ed) Handbuch der Hautu. Geschlechtskrankheiten. Ergänzungswerk, vol VII. Springer, Berlin Heidelberg New York, pp 364–39
Salamon T (1968) Genetic factors in male alopecia. In: Baccaredda-Boy A, Moretti G, Frey FR (eds) Biopathology of pattern alopecia. Karger, Basel, pp 39–49
Sansone G, Reisner RM (1971) Differential rates of conversion of testosterone to dihydrotestosterone in acne and in normal human skin. A possible pathogenic factor in acne. J Invest Dermatol 56:366–372
Savin RC (1968) The ineffectiveness of testosterone in male pattern baldness. Arch Dermatol 98:512–514
Schein M (1903) Über die Entstehung der Glatze. Wien Klin Wochenschr 16:611–615
Schmidt JB (1987) Nuclear and cytosol androgen receptor in androgen dependent dermatoses in female patients. Exp Clin Endocrinol 90:107–112
Schmidt JB, Huber J, Spona J (1985) Medroxyprogesterone acetate therapy in hirsutism. Br J Dermatol 113:161–165
Schmidt JB, Schurz B, Huber J, Spona J (1989) Hypothyreose und Hyperprolaktinämie als mögliche Ursache der androgenetischen Alopezie der Frau. Z Hautkr 64:9–12
Schmidt JB, Spona J (1987) Ein wirksames topisches Antiandrogen. 17a-propylmesterolon bei Akne. Hautarzt 38:470–473
Schumacher-Stock U, Winkler K (1977) Die externe Östrogentherapie der androgenetischen Alopezie. Hautarzt Suppl 11:336–338
Schweikert HU, Wilson JD (1974) Regulation of human hair growth by steroid hormones. I. Testosterone metabolism in isolated hairs. J Clin Endocr Metab 38:811–819
Setty LR (1970) Hair patterns of the scalp of white and negro males. Am J Phys Anthropol 33:49–55
Sheehan-Dare RA, Hughes BR, Cunliffe WJ (1988) Clinical markers of androgenicity in acne vulgaris. Br J Dermatol 119:723–730
Shi Y-P (1986) Topical minoxidil in the treatment of alopecia areata and male pattern alopecia. Arch Dermatol 122:506
Silva PD, Gentzschein EEK, Lobo RA (1987) Androstenedione may be a more important precursor of tissue dihydrotestosterone than testosterone in women. Fert Steril 48:419–422
Silvestri U (1967) Studio fisico del capello in casiusica de alopecia su base seborroica. Arch Ital Dermatol 34:405–409
Smith MA, Wells RS (1964) Male type alopecia, alopecia areata and normal hair in women; family histories. Arch Dermatol 89:95–98
Steigleder GK, Mahrle G (1973) Haarausfall als polyätiologisches Symptom. In: Braun-Falco O, Petzold D (eds) Vorträge des 7. Fortbildungskurses. Springer, Berlin Heidelberg New York, pp 237–248 (Fortschritte der praktischen Dermatologie und Venerologie, vol 7)
Storer JS, Brzuskiewicz J, Floyd H, Rice JC (1986) Review: topical minoxidil for male pattern baldness. Am J Med Sci 291:328–333
Sulzberger MB, Witten VH, Kopf AW (1960) Diffuse alopecia in women. Its unexplained apparent increase in incidence. Arch Dermatol 81:556–560
Takashima J (1974) Studies of common baldness in the stump-tailed macaque. V. Regional difference of testosterone metabolites in the hair follicles. Jpn J Derm 1:14–21
Takashima J, Montagna W (1971) Studies of common baldness of the stump-tailed macaque (Macaca speciosa). VI. The effect of testosterone on common baldness. Arch Dermatol 103:527–534
Takayasu S, Wakimoto H, Hami S, Sano S (1980) Activity of testosterone 5a-reductase activity in various tissues of human skin. J Invest Dermatol 74:187–191
Tamm J, Volkwein U, Tresguerres JAF (1980) Plasma testosterone glucosiduronate: a reliable indicator of female hyperandrogenism. Clin Endocrin 13:431–435
Tamm J, Seckelmann M, Volkwein U, Ludwig E (1982) The effect of the antiandrogen lla-hydroxyprogesterone on sebum production and cholesterol concentration of sebum. Br J Dermatol 107:63–70
Thiele FAJ (1975) Chemical aspects of hair loss and its cosmetological significance. Br J Dermatol 92:355–358
Tosti A (1986) Topical minoxidil useful in 18% of patients with androgenetic alopecia: a study of 430 cases. Dermatologica 173:136–138
Tosti A, Bardazzi F, De Padova MP, Caponeri GM, Medino M, Veronesi S (1985) Contact dermatitis to minoxidil. Contact Dermatitis 13:275–276
Uno H, Adachi K, Montagna W (1969) Baldness of the red macari. Histological properties and enzyme activities of hair follicles. J Geront 24:23–27
Uno H, Cappas A, Brigham PA (1984) Transformation of hair follicles and the therapeutic effect of minoxidil on the bald scalp of stump-tailed macaques (macaca arctoides). Chronic Derm AXVI no 4/85. Atti XXIII Congr Naz ADOI, Sorrento 1984, pp 565–583
Uno H, Cappas A, Schlägel C (1985) Cyclis dynamics of hair follicles and the effect of minoxidil on the bald scalps of stump-tailed macaques. Am J Dermatolpathol 7:283–297
Vanderveen EE, Ellis CN, Kang S, Case P, Headington JT, Voorhees JJ (1984) Topical minoxidil for hair regrowth. J Am Acad Dermatol 11:416–121
Van der Willigen AH, Peerboom-Wynia GDR, Van Joost T, Stolz E (1987) A preliminary study of lla-hydroxyprogesterone on the hair growth in men suffering from androgenetic alopecia. Acta Derm Venereol 67:82–85
Van Scott EJ, Reinertson RP, Steinmuller R (1957) The growing hair roots in the human scalp and morphological changes therein following amethopterin therapy. J Invest Dermatol 29:197–204
Venning VA, Dawber RPR (1988) Patterned androgenic alopecia in women. J Am Acad Dermatol 18:1073–1077
Verbov JL (1978) Common baldness occurring in females only, in one generation. Br J Clin Pract 32:261–262
Vermorken AJM (1983) Reversal of androgenic alopecia by minoxidil: lack of effect of simultaneously administered doses of cyproterone acetate. Acta Dermato Venereol 63:268–269
Weiss VC, West DP, Fu TS, Robinson LA, Cook B et al. (1984) Alopecia areata treated with topical minoxidil. Arch Dermatol 120:457–163
Weissmann A, Bowden J, Frank L, Horwitz S, Frost P (1985) Antiandrogenic action of topically applied spironolactone on the hamster flank organ. Arch Dermatol 121:57–62
Wendker H, Schaefer H, Zesch A (1976) Penetrationskinetik und Verteilung lokal applizierter Östrogene. Arch Dermatol Res 256:67–74
Wester RC, Maibach HI, Guy RH, Novak E (1984) Minoxidil stimulates cutaneous blood flow in human balding scalps. Pharmacodynamics measured by laser Doppler velocimetry and photopulse plethysmography. J Invest Dermatol 82:515–517
White SI, Friedman PS (1985) Topical minoxidil lacks efficacy in alopecia areata. Arch Dermatol 121:591
Winkler K (1971) Der Einfluß von Hormonen, im besonderen von Antiandrogenen, auf Seborrhoe und Haarwachstum. Zentralbl Haut Geschl Krk 46:76–78
Wüstner H, Orfanos CE (1974) Alopecia androgenetica und ihre Lokalbehandlung mit östrogen-und corticoidhaltigen Externa. Z Hautkr 49:879–888
Zappacosta AR (1980) Reversal of baldness in a patient receiving minoxidil for hypertension. N Engl J Med 303:1480
Zarate A, Mahes VB, Greenblatt RB (1966) Effect of an antiandrogen, 17a-methyl-/?-nortestos-terone, on acne and hirsutism. J Clin Endocr 26:1394–1398
Zaun H (1969) Wachstumsstörungen der Kopfhaare als Folge von Hepatopathien. Arch Klin Exp Dermatol 235:386–393
Zaun H (1970) Über den Einfluß einiger ovulationshemmender Hormonkombinationen auf das Wachstum der Haare. Dtsch Med Wochenschr 95:1433–1436
Zaun H (1971) Ovulationshemmer als Behandlung der androgenetischen Alopecie bei der Frau. Hautarzt 22:594
Zaun H (1973) Haarwuchsstörungen nach Sexualhormontherapie bei Haarwuchsstörungen. Hautarzt 24:1–6
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Orfanos, C.E. (1990). Androgenetic Alopecia: Clinical Aspects and Treatment. In: Orfanos, C.E., Happle, R. (eds) Hair and Hair Diseases. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-74612-3_19
Download citation
DOI: https://doi.org/10.1007/978-3-642-74612-3_19
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-74614-7
Online ISBN: 978-3-642-74612-3
eBook Packages: Springer Book Archive